Funding Details
- Awarder
- SOSV
- Date Award
- May 13, 2024
- Vertical
- Microbiome
- Funding URL
- View Funding Page
Company Info
- Founding Year
- None
- Traction
- None
- Organizations Involved
- None
- Founders
- Christoph Geisler, James Francis
- Company Description
- Unlocked is developing probiotics with enhanced abilities to take up and break down compounds in the GI tract – thereby safely bringing down levels throughout the human body. Our platform approach is to activate dormant probiotic genes, enabling Unlocked to target specific compounds that are the root causes of serious chronic health conditions. We’re cutting out the onerous FDA drug approval process by exploiting the GRAS status, medical food, route. This allows us to perfect our product market fit before starting the clinical trials that will provide the scientific backing consumers are looking for.
- Market
- Human Health
- Location
-
United States
- Coinvestors
- None
Links